78 до 500/ 125 mg, два пъти дневно, при едновременното приложение с ефавиренц 600 mg веднъж дневно.
Cardiac events have been reported with Kaletra in preclinical studies; therefore, the potential cardiac effects of Kaletra cannot be currently ruled out (see sections 4.8 and 5.3).